Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Pak IncfiledCriticalMicro Pak Inc
Priority claimed from PCT/US1995/000475external-prioritypatent/WO1995022989A1/en
Publication of MX9603547ApublicationCriticalpatent/MX9603547A/en
The present invention features an adjuvanted vaccine, and methods for preparing an adjuvanted vaccine, preferably for immunizing against influenza, where the adjuvant is a lipid vesicle, and preferably is a nonphospholipid, paucilamellar lipid vesicle. The antigen may be encapsulated in the central cavity of the adjuvant, or mixed in solution with the adjuvant. Moreover, the adjuvant may carry a secondary adjuvant to further improve the immune response.
MX9603547A1995-01-111995-01-11Vaccines containing paucilamellar lipid vesicles as immunological adjuvants.
MX9603547A
(en)
Synthesis of an antigenic determinant of the HSV gD that stimulates the induction of virus-neutralizing antibodies and confers protection against a lethal challenge of HSV.